Real-world experience using hydroxyurea in children with sickle cell disease in Lilongwe, Malawi

INTRODUCTION: Sickle cell disease (SCD) is among the most common inherited hematologic diseases in sub-Saharan Africa (SSA). Historically, hydroxyurea administration in SSA has been restricted due to limited region-specific evidence for safety and efficacy. METHODS: We conducted a prospective observ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Mvalo, Tisungane, Topazian, Hillary M., Kamthunzi, Portia, Chen, Jane S., Kambalame, Isobel, Mafunga, Pilirani, Mumba, Noel, Chiume, Msandeni, Paseli, Khadija, Tegha, Gerald, Kumwenda, Wiza, Heimlich, J. Brett, Ellis, Graham, Key, Nigel, Gopal, Satish, Hoffman, Irving, Ataga, Kenneth I., Westmoreland, Kate D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6754288/
https://ncbi.nlm.nih.gov/pubmed/31397075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.27954
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados